{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:03:52Z","timestamp":1783778632809,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2021LK054"],"award-info":[{"award-number":["2021LK054"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e33779","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T15:10:41Z","timestamp":1719501041000},"page":"e33779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of the combined use of ivabradine and metoprolol in patients with acute myocardial infarction early after percutaneous coronary intervention: A randomized controlled study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8146-3300","authenticated-orcid":false,"given":"Ruiqing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9638","key":"10.1016\/j.heliyon.2024.e33779_bib1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","article-title":"Acute myocardial infarction","volume":"372","author":"White","year":"2008","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33779_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","article-title":"Adverse remodeling and reverse remodeling after myocardial infarction","volume":"19","author":"Bhatt","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.heliyon.2024.e33779_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2018.05.017","article-title":"Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure","volume":"271","author":"Dobre","year":"2008","journal-title":"Int. J. Cardiol."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e33779_bib4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33779_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1536\/ihj.21-355","article-title":"Optimal heart rate modulation using ivabradine","volume":"62","author":"Imamura","year":"2021","journal-title":"Int. Heart J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33779_bib6","first-page":"e449","article-title":"Ivabradine: a new frontier in the treatment of stable coronary artery disease and chronic heart failure","volume":"171","author":"Gammone","year":"2020","journal-title":"Clin. Ter."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33779_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/clc.23581","article-title":"Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: meta-analysis of randomized controlled trials","volume":"44","author":"Bryan Richard","year":"2021","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33779_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33779_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cardfail.2009.05.013","article-title":"Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings","volume":"15","author":"Fasullo","year":"2009","journal-title":"J. Card. Fail."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33779_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/0735-1097(92)90314-D","article-title":"Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape","volume":"19","author":"Mitchell","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33779_bib11","first-page":"582","article-title":"Overview of \"China cardiovascular health and disease report 2020\"","volume":"19","year":"2021","journal-title":"Chinese Journal of Cardiovascular Research"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33779_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006181","volume":"6","author":"Kosmidou","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33779_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/hr.2013.98","article-title":"Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease","volume":"36","author":"Inoue","year":"2013","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33779_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2010.02.017","article-title":"Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"211","author":"Parodi","year":"2010","journal-title":"Atherosclerosis"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e33779_bib15","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehn447","article-title":"High resting heart rate: a cardiovascular risk factor or a marker of risk?","volume":"29","author":"Escobar","year":"2008","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33779_bib16","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.3390\/ijms24032801","article-title":"Therapeutic use and molecular aspects of ivabradine in cardiac remodeling: a Review","volume":"24","author":"Kamisah","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33779_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.acvd.2013.12.001","article-title":"Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: a pilot study","volume":"107","author":"Gerbaud","year":"2014","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33779_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40261-016-0424-9","article-title":"Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study","volume":"36","author":"Barill\u00e0","year":"2016","journal-title":"Clin. Drug Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33779_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12816","article-title":"Effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a pilot test","volume":"26","author":"Xu","year":"2021","journal-title":"Ann. Noninvasive Electrocardiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33779_bib20","first-page":"25","article-title":"Ivabradine in patients with acute ST-elevation myocardial infarction: a meta-analysis of randomized controlled trials, Egypt","volume":"75","author":"Sasmita","year":"2023","journal-title":"Hear. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33779_bib21","first-page":"630","article-title":"Value of ivabradine in patients with anterior ST-elevation myocardial Infarction: the VIVA-STEMI study, Cardiol","volume":"4","author":"Rezq","year":"2020","journal-title":"Cardiovasc. Med."},{"issue":"9641","key":"10.1016\/j.heliyon.2024.e33779_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.heliyon.2024.e33779_bib23","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","article-title":"Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy","volume":"32","author":"Tardif","year":"2011","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33779_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.hjr.0000189807.22224.54","article-title":"Prognostic value of time-related changes of cardiopulmonary exercise testing indices in stable chronic heart failure: a pragmatic and operative scheme","volume":"13","author":"Corr\u00e0","year":"2006","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33779_bib25","first-page":"173","article-title":"Cardiac rehabilitation fitness changes and subsequent survival","volume":"4","author":"Schutter","year":"2018","journal-title":"Eur. Heart. J. Qual. Care. Clin. Outcomes."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33779_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/108155890405200634","article-title":"Parasympathetic effects on heart rate recovery after exercise","volume":"52","author":"Kannankeril","year":"2004","journal-title":"J. Invest. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33779_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2008.11.004","article-title":"Usefulness of abnormal heart rate recovery on exercise stress testing to predict high-risk findings on single-photon emission computed tomography myocardial perfusion imaging in men","volume":"103","author":"Gera","year":"2009","journal-title":"Am. J. Cardiol."},{"issue":"9744","key":"10.1016\/j.heliyon.2024.e33779_bib28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33779_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/apm-21-2993","article-title":"Analysis of correlation between heart failure in the early stage of acute myocardial infarction and serum pregnancy associated plasma protein-A, prealbumin, C-reactive protein, and brain natriuretic peptide levels","volume":"11","author":"Yang","year":"2022","journal-title":"Ann. Palliat. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33779_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.18087\/cardio.2020.11.n1309","article-title":"Early predictors of heart failure progression in patients after myocardial infarction","volume":"60","author":"Oleynikov","year":"2020","journal-title":"Kardiologiia"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33779_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MAJ.0b013e31825b5f95","article-title":"Effect of initial heart rate on cardiac troponin and ejection fraction in patients with non-ST segment elevation myocardial infarction","volume":"344","author":"Chughtai","year":"2012","journal-title":"Am. J. Med. Sci."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e33779_bib32","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehn337","article-title":"Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction","volume":"29","author":"Heusch","year":"2008","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e33779_bib33","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1111\/bph.13220","article-title":"Pleiotropic, heart rate-independent cardioprotection by ivabradine","volume":"172","author":"Kleinbongard","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33779_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002989","article-title":"Heart rate reduction with ivabradine protects against left ventricular remodeling by attenuating infarct expansion and preserving remote-zone contractile function and synchrony in a mouse model of reperfused myocardial infarction","volume":"5","author":"O'Connor","year":"2016","journal-title":"J. Am. Heart Assoc."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024098104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024098104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:43:25Z","timestamp":1778885005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024098104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024098104"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33779","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the combined use of ivabradine and metoprolol in patients with acute myocardial infarction early after percutaneous coronary intervention: A randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33779"}}